Assessment of Treatment Response to Lenvatinib in Thyroid Cancer Monitored by F-18 FDG PET/CT Using PERCIST 1.0, Modified PERCIST and EORTC Criteria—Which One Is Most Suitable?

por Rendl, Gundula, Schweighofer-Zwink, Gregor, Sorko, Stefan, Gallowitsch, Hans-Jürgen, Hitzl, Wolfgang, Reisinger, Diana, Pirich, Christian
Publicado 2022